Current state of corticosteroid therapy in patients with septic shock

Clinical Intensive Care

Volumn 16, Issue 3-4, 2005, Pages 151-161

  Keh, Didier ^a   Feldheiser, Aarne ^a   Ahlers, Olaf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Glucocorticoids; Hydrocortisone; Review; Sepsis; Septic shock

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; BLOOD VESSEL TONE; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; HOMEOSTASIS; HORMONE RELEASE; HOST RESISTANCE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INFECTION RESISTANCE; INFLAMMATION; LOW DRUG DOSE; MORTALITY; NEUROENDOCRINOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; STRESS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33746815231     PISSN: 09563075     EISSN: 14737752     Source Type: Journal    
DOI: 10.1080/09563070512331391309     Document Type: Review

References (70)

1. Chrousos, GP. (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation N Engl J Med, 332, pp. 1351-62.
2. Sapolsky, RM and Romero, LM and Munck, AU. (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocr Rev, 21, pp. 55-89.
3. Webster, JI and Sternberg, EM. (2004) Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products J Endocrinol, 181, pp. 207-21.
4. Meduri, GU. (1999) An historical review of glucocorticoid treatment in sepsis. Disease pathophysiology and the design of treatment investigation Sepsis, 3, pp. 21-38.
5. Rothwell, PM and Udwadia, ZF and Lawler, PG. (1991) Cortisol response to corticotropin and survival in septic shock Lancet, 337, pp. 582-3.
6. Briegel, J and Forst, H and Hellinger, H and (1991) Contribution of cortisol deficiency to septic shock Lancet, 338, pp. 507-8.
7. Dellinger, RP and Carlet, JM and Masur, H and (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med, 32, pp. 858-73.
8. Keh, D and Sprung, CL. (2004) Use of corticosteroid therapy in patients with sepsis and septic shock: An evidence-based review Crit Care Med, 32, pp. S527-3.
9. Webster, JI and Tonelli, L and Sternberg, EM. (2002) Neuroendocrine regulation of immunity Annu Rev Immunol, 20, pp. 125-63.
10. Arlt, W and Allolio, B. (2003) Adrenal insufficiency Lancet, 361, pp. 1881-93.
11. Oelkers, W. (1996) Adrenal insufficiency N Engl J Med, 335, pp. 1206-12.
12. Bornstein, SR and Chrousos, GP. (1999) Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs J Clin Endocrinol Metab, 84, pp. 1729-36.
13. Marik, PE and Zaloga, GP. (2003) Adrenal insufficiency during septic shock Crit Care Med, 31, pp. 141-5.
14. Vermes, I and Beishuizen, A and Hampsink, RM and (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone J Clin Endocrinol Metab, 80, pp. 1238-42.
15. Melby, JC and Spink, WW. (1958) Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in pattients with shock due to infection J Clin Invest, 37, pp. 1791-8.
16. Annane, D and Sebille, V and Troche, G and (2000) 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin JAMA, 283, pp. 1038-45.
17. Matot, I and Sprung, CL. (1998) Corticosteroids in septic shock: Resurrection of the last rites? Crit Care Med, 26, pp. 627-9.
18. Beishuizen, A and Thijs, LG and Vermes, I. (2001) Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma Intensive Care Med, 27, pp. 1584-91.
19. Meduri, GU and Tolley, EA and Chrousos, GP and (2002) Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids Am J Respir Crit Care Med, 165, pp. 983-91.
20. Cooper, MS and Stewart, PM. (2003) Corticosteroid insufficiency in acutely ill patients N Engl J Med, 348, pp. 727-34.
21. Marik, PE and Zaloga, GP. (2002) Adrenal insufficiency in the critically ill: A new look at an old problem Chest, 122, pp. 1784-96.
22. Annane, D and Cavaillon, JM. (2003) Corticosteroids in sepsis: From bench to bedside? Shock, 20, pp. 197-207.
23. Hamrahian, AH and Oseni, TS and Arafah, BM. (2004) Measurements of serum free cortisol in critically ill patients N Engl J Med, 350, pp. 1629-38.
24. Newton, R. (2000) Molecular mechanisms of glucocorticoid action: What is important? Thorax, 55, pp. 603-13.
25. Franchimont, D and Kino, T and Galon, J and (2003) Glucocorticoids and Inflammation Revisited: The State of the Art. NIH Clinical Staff Conference Neuroimmunomodulation, 10, pp. 247-60.
26. Walker, G and Pfeilschifter, J and Kunz, D. (1997) Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post- transcriptional regulation J Biol Chem, 272, pp. 16679-87.
27. Simmons, WW and Ungureanu Longrois, D and Smith, GK and (1996) Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport J Biol Chem, 271, pp. 23928-37.
28. Wu, CC and Croxtall, JD and Perretti, M and (1995) Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat Proc Natl Acad Sci USA, 92, pp. 3473-7.
29. Buttgereit, F and Scheffold, A. (2002) Rapid glucocorticoid effects on immune cells Steroids, 67, pp. 529-34.
30. Lösel, RM and Feuring, M and Falkenstein, E and (2002) Nongenomic effects of aldosterone: Cellular aspects and clinical implications Steroids, 67, pp. 493-8.
31. Haseroth, K and Gerdes, D and Berger, S and (1999) Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice Biochem Biophys Res Commun, 266, pp. 257-61.
32. Wehling, M and Spes, CH and Win, N and (1998) Rapid cardiovascular action of aldosterone in man J Clin Endocrinol Metab, 83, pp. 3517-22.
33. Ullian, ME. (1999) The role of corticosteriods in the regulation of vascular tone Cardiovasc Res, 41, pp. 55-64.
34. Brealey, D and Karyampudi, S and Jacques, TS and (2004) Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure Am J Physiol Regul Integr Comp Physiol, 286, pp. R491-7.
35. Vincent, JL and Zhang, H and Szabo, C and (2000) Effects of nitric oxide in septic shock Am J Respir Crit Care Med, 161, pp. 1781-5.
36. Landry, DW and Oliver, JA. (2001) The pathogenesis of vasodilatory shock N Engl J Med, 345, pp. 588-95.
37. Lopez, A and Lorente, JA and Steingrub, J and (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock Crit Care Med, 32, pp. 21-30.
38. Radomski, MW and Moncada, S. (1993) Regulation of vascular homeostasis by nitric oxide Thromb Haemost, 70, pp. 36-41.
39. Sundrani, R and Easington, CR and Mattoo, A and (2000) Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats Crit Care Med, 28, pp. 2898-903.
40. De Backer, D and Creteur, J and Preiser, JC and (2002) Microvascular blood flow is altered in patients with sepsis Am J Respir Crit Care Med, 166, pp. 98-104.
41. Spronk, PE and Ince, C and Gardien, MJ and (2002) Nitroglycerin in septic shock after intravascular volume resuscitation Lancet, 360, pp. 1395-6.
42. Salyapongse, AN and Billiar, TR.(2000) Nitric oxide as a modulator of sepsis: Therapeutic possibilities. In Multiple organ failure. Pathophysiology, prevention, and therapy. (pp. 176-87). New York: Springer Verlag.
43. Radomski, MW and Palmer, RM and Moncada, S. (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells Proc Natl Acad Sci USA, 87, pp. 10043-7.
44. Hafezi-Moghadam, A and Simoncini, T and Yang, E and (2002) Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase Nat Med, 8, pp. 473-9.
45. Keh, D and Boehnke, T and Weber-Carstens, S and (2003) Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study Am J Respir Crit Care Med, 167, pp. 512-20.
46. Vallance, P and Rees, D and Moncada, S.(2000) Therapeutic potential of NOS inhibitors in septic shock. In Nitric Oxide. (pp. 385-97). Berlin: Springer Verlag.
47. Huettemann, E and Bernhardt, A and Schelenz, C and (2003) Low dose hydrocortisone does not influence myocardial function in patients with septic shock Intensive Care Med, 29, pp. S154.
48. Annane, D and Bellissant, E and Bollaert, PE and (2004) Corticosteroids for severe sepsis and septic shock: A systematic review and meta-analysis BMJ, 329, pp. 480.
49. Annane, D and Sebille, V and Charpentier, C and (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA, 288, pp. 862-71.
50. Oppert, M and Reinicke, A and Gräf, KJ and (2000) Plasma cortisol levels before and during 'low-dose' hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock Intensive Care Med, 26, pp. 1747-55.
51. Annane, D and Bellissant, E and Sebille, V and (1998) Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve Br J Clin Pharmacol, 46, pp. 589-97.
52. Minneci, PC and Deans, KJ and Banks, SM and (2004) Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose Ann Intern Med, 141, pp. 47-56.
53. Franchimont, D. (2004) Overview of the actions of glucocorticoids on the immune response: A good model to characterize new pathways of immunosuppression for new treatment strategies Ann N Y Acad Sci, 1024, pp. 124-37.
54. Galon, J and Franchimont, D and Hiroi, N and (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells FASEB J, 16, pp. 61-71.
55. Meduri, GU and Kanangat, S and Bronze, M and (2001) Effects of methylprednisolone on intracellular bacterial growth Clin Diagn Lab Immunol, 8, pp. 1156-63.
56. Silverstein, R and Johnson, DC. (2003) Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis J Leukoc Biol, 73, pp. 417-27.
57. Sadeghi, R and Hawrylowicz, CM and Chernajovsky, Y and (1992) Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes Cytokine, 4, pp. 287-97.
58. Shen, L and Guyre, PM and Ball, ED and (1986) Glucocorticoid enhances gamma interferon effects on human monocyte antigen expression and ADCC Clin Exp Immunol, 65, pp. 387-95.
59. Watanabe, Y and Lee, S and Allison, AC. (1990) Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: Down-regulation by IL- 1 but not by IL-6, prostaglandin E2, or glucocorticoids Scand J Immunol, 32, pp. 601-9.
60. Confalonieri, M and Urbino, R and Potena, A and (2005) Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study Am J Respir Crit Care Med, 171, pp. 242-8.
61. Van Den Berghe, G and Wouters, P and Weekers, F and (2001) Intensive insulin therapy in the critically ill patients N Engl J Med, 345, pp. 1359-67.
62. Weber-Carstens, S and Deja, M and Hokema, F and (2005) Impact of continuous versus bolus low dose hydrocortisone application on blood glucose in septic shock patients Crit Care, 9, pp. S162.
63. Herridge, MS and Cheung, AM and Tansey, CM and (2003) One-year outcomes in survivors of the acute respiratory distress syndrome N Engl J Med, 348, pp. 683-93.
64. De Jonghe, B and Sharshar, T and Lefaucheur, JP and (2002) Paresis acquired in the intensive care unit: A prospective multicenter study JAMA, 288, pp. 2859-67.
65. Briegel, J and Forst, H and Haller, M and (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study Crit Care Med, 27, pp. 723-32.
66. Annane, D and Briegel, J and Keh, D and (2003) Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone Crit Care Med, 31, pp. 2250-1.
67. Keh, D and Gerlach, H.(2004) Low-dose corticosteroids in septic shock. In Yearbook of Intensive Care and Emergency Medicine. (pp. 123-36). Heidelberg: Springer Verlag.
68. Briegel, J and Jochum, M and Gippner-Steppert, C and (2001) Immunomodulation in septic shock: Hydrocortisone differentially regulates cytokine responses J Am Soc Nephrol, 12, pp. S70-S74.
69. Briegel, J and Kellermann, W and Forst, H and (1994) Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group Clin Investig, 72, pp. 782-7.
70. Mussack, T and Briegel, J and Schelling, G and (2005) Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock Clin Chem Lab Med, 43, pp. 259-68.